How AI Brings Pharmacogenetics to the Frontline of Precision Medicine
Pharmacy Times
JULY 22, 2025
A man aged 55 years with metastatic colorectal cancer was initiated on a standard fluoropyrimidine-based chemotherapy regimen. Early identification of genetic markers associated with treatment efficacy or adverse reactions helps reduce late-stage clinical trial failures and improves the overall efficiency of the development pipeline.
Let's personalize your content